The movies of 2013: Sequels, science fiction will lead the

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

The movies of 2013: Sequels, science fiction will lead the way

Updated:   01/06/2013 04:27:08 PM PST


(L-R): Charlie Hunnam as Raleigh Beckett and Rinko Kikuchi as Mako Mori in Warner Bros. Pictures' and Legendary Pictures' sci-fi action adventure, "Pacific Rim," a Warner Bros. Pictures release. (Kerry Hayes)

Following a year of record box-office sales, increased attendance and even happy critics, the movies of 2013 have a lot to live up to.

Some observers feel that this year's total gross may beat 2012's mighty $10.8 billion. Mostly because of the kinds of movies that make critics sad - sequels, crude comedies, formulaic animated films - but hey, whatever sells.

Studios are hoping some of that will come from expanding the "Twilight"/"Hunger Games" audience to adaptations of such young adult novels as "Beautiful Creatures" (currently set for release on Feb. 13), "The Mortal Instruments: City of Bones" (Aug. 23), Stephenie Meyer's "The Host" (March 29) and "Ender's Game" (Nov. 1).

Another hope is that the intelligent

From producer Jerry Bruckheimer and director Gore Verbinski comes Disney/Bruckheimer Films' "The Lone Ranger." Tonto (Johnny Depp, left), a spirit warrior on a personal quest, joins forces in a fight for justice with John Reid (Armie Hammer), a lawman who has become a masked avenger. (Peter Mountain)
science fiction trend of the last few years will look even better with big money behind it, as half a dozen original, well-funded futuristic fantasies are on 2013's schedule.

Mostly, though, optimism is grounded, as it always is in Hollywood, on a whole lot more of the tried and true.

"This year just looks incredible," Paul Dergarabedian, president of Hollywood.com 's Box-Office Division, enthused. "Obviously, there's going to be another `Hobbit' and there's going to be another `Hunger Games.' But there's also going to be the next `Iron Man' and `Thor,' there's going to be the next `Star Trek' movie, which looks really cool to me.

"There will be `Fast & Furious 6', `Man of


Advertisement

Steel,' the next Superman movie, another `Anchorman' movie," Dergarabedian continued, "just a tremendous lineup for the new year."

Also among more than 25 franchise movies scheduled for 2013 release are "The Hangover Part III" (currently set for release on May 24); "Monsters University," a prequel to Pixar's "Monsters, Inc." (June 21); "G.I. Joe: Retaliation" (March 29); "Grown Ups 2" (July 12); "A Good Day to Die Hard" (Feb. 14); "300: Rise of an Empire" (Aug. 2); "RED 2" (Aug. 2); and, inevitably, "Scary Movie 5" (April 12).

Such a repetitive list leaves other industry watchers more than a little depressed.

"It just looks awful to me," lamented Anne Thompson, editor-in-chief of Thompson on Hollywood at Indiewire.com . "It's all horrible sequels and remakes, the usual dreck. I'm not looking forward to `Smurfs 2.' `Cloudy with Meatballs 2'? This is not my idea of a good time."

That said, Thompson admitted she was eagerly anticipating "Into Darkness" (May 17), J.J. Abrams' sequel to his successful "Star Trek" reboot, and she thought the second "Hunger Games: Catching Fire" (Nov. 21) movie looks kinda nifty.

What Thompson's really charged up about, though,

(L to R): Tobey Maguire as Nick Carraway and Leonardo DiCaprio as Jay Gatsby in Warner Bros. Pictures' and Village Roadshow Pictures' drama "The Great Gatsby," a Warner Bros. Pictures release. (Courtesy of Warner Bros. Pictures)
is the sci-fi slate made by such well-regarded directors as Guillermo del Toro, Neil Blomkamp and Alfonso Cuaron.

"I am looking forward to Guillermo del Toro pitting giant robots against giant monsters in `Pacific Rim'," Thompson said. "And I am looking forward to some of the ones that other people want to see. They include (Blomkamp's) `Elysium' and a lot of dystopian films that lend themselves to some visual panache."

But what about those who like a little reality in their cinema?

Considering how well 2012 releases "Lincoln," "Argo," "Flight," "Zero Dark Thirty," and others have done in theaters, that audience is more substantial than it has been in years.

It may not be as well-served in 2013 as it was in 2012, but there are some serious movies on the schedule, and more will surely be added as the fall approaches.

"You've got `The Wolf of Wall Street' coming from Martin Scorsese, with Leonardo DiCaprio," Thompson noted.

The jury's out on Baz Luhrmann's "The Great Gatsby," which was bounced from a 2012 year-end awards consideration slot to May 10 of this year, despite starring DiCaprio as F. Scott Fitzgerald's Jazz Age antihero.

On the other hand, "The Monuments Men" (Dec. 20), George Clooney's latest directing effort starring himself, Daniel Craig and Matt Damon, sounds good sight unseen; it's about art experts trying to save Europe's treasures from the Nazis during World War II.

Ditto for Paul Greengrass' true-life tale of a ship skipper captured by Somali pirates, "Captain Phillips" (Oct. 11), starring Tom Hanks.

Hanks also plays Walt Disney in "Saving Mr. Banks" (Dec. 20), a tale about the struggle (who knew?) to bring "Mary Poppins" to the screen.

Sports biopics will include "42" (April 12), with Chadwick Boseman as Jackie Robinson and Harrison Ford as Branch Rickey, and Ron Howard's "Rush" (Sept. 20), with Chris Hemsworth and Daniel Bruhl as rival Formula One racers.

There will also be the odd sight of Ashton Kutcher bringing the Apple genius back to life in "Jobs."

Guess it's time to talk about comedy.

Along with the aforementioned sequels, we can anticipate the crazier-in-the-movies-than-she-is-on-TV Melissa McCarthy to headline two features, "Identity Thief" (Feb. 8) and "The Heat" (April 5), the latter by the director of her "Bridesmaids" breakthrough, Paul Feig.

Expect to see the rest of the Judd Apatow gang (Seth Rogen, James Franco, etc.) not deal well with the apocalypse in "This Is the End" (June 14), while Edgar Wright's similarly beloved English cut-up crew faces a similar plot complication in "The World's End" (Oct. 25).

Meanwhile, the less prolific comedy team of Vince Vaughn and Owen Wilson try to recapture that "Wedding Crashers" magic with "The Internship" (June).

Maybe 2013's mother of comedy pairings will be Steve Carell, Jim Carrey and, um, Steve Buscemi in "The Incredible Burt Wonderstone" (March 15).

Robert De Niro, Michael Douglas, Morgan Freeman and Kevin Kline will try to give them a run for their money in "Last Vegas" (Dec. 20), a kind of AARP take on the "Hangover" recipe.

Enough laughs. Hollywood's most serious business every year is creating new blockbuster franchises.

The biggest bet of 2013 is being placed on "The Lone Ranger" (July 3), from the same director, producer and Johnny Depp that gave us "Pirates of the Caribbean."

Also on the more-of-the-same-but-different list is "Independence Day" landmark defiler Roland Emmerich's "White House Down" (June 28), with Secret Service guy Channing Tatum trying to save President Jamie Foxx from paramilitary home invaders.

Will Franco as "Oz: The Great and Powerful" (March 8) or Brad Pitt fighting "World War Z" (June 21) start series? Uncertain at this point.

For the boys (and certain visually-oriented girls) "Pain & Gain" (April 26), with an iron-pumping Mark Wahlberg and Dwayne Johnson, may not be Michael Bay's next "Transformers," but could hit kinda big. The ladies may be less attracted to the well-worn physiques of Arnold Schwarzenegger and Sylvester Stallone, but the old action boys are hoping their latest team-up, "The Tomb" (Sept. 27), will be this year's "Expendables."

We'll see what works.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TDS Kills Array Merger, Revives Stock Buyback Plans

Updated Category News Views 1

Shifting Gears: TDS Drops Array Deal There's always something brewing in the halls of corporate mergers. Just when you thought Telephone and Data Systems, Inc. (TDS) was about to cinch a deal with Array Digital Infrastructure, Inc. (NYSE: AD), they've turned the car around. TDS decided it won't be going ahead with its acquisition of the remaining shares it doesn't already...

Continue Reading
TaxRock's New Platform Takes on IRS Complexity

Updated Category News Views 0

An AI Solution Tackles IRS Complexity Right out of the gates, TaxRock is shaking things up in the tax world with its latest rollout. While the word 'IRS' rarely sparks a grin, the California company aims to change the way folks handle their tax data. Their new consumer platform promises to lace taxpayers' frazzled nerves with the calm structure of AI. Let's face it—most...

Continue Reading
SCO at 25: China's Strategic Push for Regional Growth

Updated Category News Views 2

There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...

Continue Reading
Tiger Group Offloads High-End Equipment in Swift Sale

Updated Category News Views 7

Fast Moves in Manufacturing Equipment Liquidation Alright, gather 'round. Tiger Commercial & Industrial (C&I) recently wrapped up a speedy sale of high-precision fabrication and assembly machinery from two U.S. plants. We're talking about substantial inventory here, including equipment from once-bustling facilities in Alpharetta, Georgia, and Dallas, Texas. This wasn't...

Continue Reading
Broadridge Expands Tokenization with G7 Securities

Updated Category News Views 0

Broadridge Takes a Big Step with G7 Integration Broadridge Financial Solutions is pulling no punches with its latest move—integrating G7 securities into its Distributed Ledger Repo (DLR) network. This isn't your average fintech maneuver; it's a heavyweight shift intended to redefine the way global financing and collateral markets work. Tokenized Repo: More Than Just a...

Continue Reading
Newmark Expands with Bold Acquisition of Altus Group Unit

Updated Category News Views 3

Newmark's Strategic Expansion Continues Nothing like a splashy acquisition to get tongues wagging in the crowded halls of commercial real estate. Newmark Group, Inc. (NASDAQ:NMRK) just closed the deal on Altus Group Limited's Development Advisory business—a move that injects 335 sharp minds into Newmark's already potent Project Management arsenal. Now, that's a...

Continue Reading
How Shelton's Property Taxes Influence Housing Costs

Updated Category News Views 2

Thinking about snapping up a home in Shelton, Connecticut? Well, you might want to keep an eye on those property taxes first. Sure, mortgage rates and listing prices grab all the initial attention, but taxes—oh boy, they know how to creep up on ya. Matt Nuzie from RE/MAX lays it bare: property taxes can make or break the bank for homebuyers in Fairfield County. So,...

Continue Reading
Union Savings Bank Leverages AI for Strategic Growth

Updated Category News Views 4

USB's Data-Driven Approach Transforms Banking Remember the days of handing out toasters to keep customers? Union Savings Bank (USB) sure doesn't seem to, as it embraces tech-savvy methods to keep its clientele content. Instead, the $3.3 billion community bank based in Danbury, Connecticut, has deployed NGDATA's AI Hub, transforming its approach to reducing customer churn...

Continue Reading
NEXA Unlimited: Disrupting Mortgage Broker Earnings

Updated Category News Views 1

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

Continue Reading
Operation Onward's Reach Shatters Expectations Early

Updated Category News Views 2

Broaching a niche audience isn't a walk in the park, yet REE Medical's Operation Onward thinks otherwise. With its first episode overshooting reach goals by a handsome 60%, this brand new series is already making waves. The show, which digs into veteran experiences with real flesh and bone stories, is clearly resonating. An Unexpected Hit Launching on August 4th, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Schroeder MD Regenerative Orthopedics Enhances Patient Care

Updated Category News Views 115

Schroeder MD Regenerative Orthopedics Expands Its Reach Schroeder MD Regenerative Orthopedics (SRO), founded by distinguished orthopedic surgeon Keith E. Schroeder, MD, is thrilled to unveil its second location in a bustling area. This new clinic, conveniently located nearby well-known shopping spots, marks an exciting step in the company's mission to provide enhanced...

Continue Reading
Aker ASA Shares Acquisition Under Employee Program

Updated Category News Views 118

Aker ASA Shares Acquisition Under Employee Program Aker ASA recently took a pivotal step by acquiring 6,526 of its own shares at an average price of NOK 534.53 per share. This transaction reflects the company's ongoing commitment to its employees through its share program. Details of the Share Acquisition The purchase of these shares was made on the Oslo Stock Exchange...

Continue Reading
Exploring Smart Cities and Innovations in Digital Real Estate

Updated Category News Views 106

Understanding the Impact of Digital Technology on Real Estate During the recent summit focused on real estate innovations, key stakeholders gathered to discuss how advancements like Digital Twins, Blockchain, and AI are revolutionizing the industry. This event, held at an iconic venue, featured insightful discussions, encouraging attendees to envision a future where...

Continue Reading
Neumora Therapeutics Faces Challenges Amidst Market Volatility

Updated Category News Views 117

Neumora Therapeutics Stock Struggles Amid Market Pressures Neumora Therapeutics Inc. (NMRA) has experienced significant stock decline, recently hitting a 52-week low of $1.89 as it grapples with a tumultuous market. While the company has managed to maintain a FAIR financial health score, analysts have set ambitious price targets ranging from $15 to $30. This biotechnology...

Continue Reading
Important Gathering to Discuss Future Directions of AS Storebælt

Updated Category News Views 47

Overview of the Extraordinary General Meeting The upcoming extraordinary general meeting is an important event aimed at uniting stakeholders to discuss significant developments related to AS Storebælt. These gatherings play a vital role in ensuring that the company’s direction aligns with shareholder expectations while also addressing any emerging issues. Attendees...

Continue Reading